|
Dementia risk among post-menopausal women treated with endocrine therapy for early-stage breast cancer in Ontario, Canada. |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Honoraria - Amgen; Eisai; Genomic Health International; Myriad Genetics; Novartis; Pfizer; Roche |
Consulting or Advisory Role - Amgen; Eisai; Genomic Health International; Myriad Genetics; Novartis; Pfizer; Roche |
Travel, Accommodations, Expenses - Amgen; Eisai; Genomic Health International; Myriad Genetics; Novartis; Pfizer; Roche |
|
|
|
Consulting or Advisory Role - Lilly |
|
|
Consulting or Advisory Role - Roche Canada |
Travel, Accommodations, Expenses - Roche Canada |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Patents, Royalties, Other Intellectual Property - UpToDate |